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Transgenic mice were produced by microinjection of a DNA construct composed of the bovine K-casein (K-CN) 
cDNA under the control of the goat Jj-CN 5' promoter elements and 3' flanking regions into pronuclear-stage 
embryos. The gene construct targeted the expression of bovine K-CN RNA to the mammary gland and secretion of 
bovine K-CN in the milk. In the three lines studied (BC-7, BC-31 and BC-67) the transgene was stably integrated 
and propagated as a Mendelian locus. Expression of the bovine protein in lactating mice from the three transgenic 
lines was demonstrated by northern and western blots. In ten different tissues analysed by northern blotting, 
expression was confined to the mammary gland of lactating transgenic mice from line BC-7, with low-level 
expression also observed in the salivary gland of lines BC-31 and BC-67. Transgene expression in the mammary 
gland paralleled normal casein gene expression during lactation and was not observed in virgin females. The level 
of bovine K-CN mRNA expression on day 10 of lactation in hemizygous transgenic females in relation to 
endogenous mRNA of whey acid protein (WAP) gene expression was 14%, 69% and 127% in lines BC-7, BC-31 
and BC-67, respectively. No association between transgene copy number and expression was observed. The bovine 
K-CN concentration in milk on day 10 of lactation ranged from 0.94 to 3.85 mg of protein per ml of milk. The 
bovine K-CN expressed in mouse milk had the same molecular mass and immunoactivity with polyclonal 
antibodies as did K-CN from bovine milk. A high degree of variation in the production of bovine K-CN within each 
of the transgenic lines was observed. 
Keywords: bovine K-casein; transgenic; tissue specificity; mouse milk 
Introduction cheese can potentially be achieved by genome incorpora­
tion of additional casein genes. 
The manipulation of milk composition by gene transfer Caseins are the major protein component of milk and 
has considerable potential for the ilnprovement of dairy are stored and secreted in the form of stable calcium­
animals, both for production of biomedical proteins and phosphate micelles. The micelles are composed of a s]-, 
for direct manipulation of milk composition (for reviews asT' and I3-CN, which interact with calcium and K-CN 
see Wall et al., 1992; Yom and Bremel, 1993). Modifica­ (Waugh, 1971) found predominantly on the surface of the 
tion of the casein (CN) components to improve the micelle (Schmidt, 1982). The structure and physical 
manufacturing properties of milk and the production of stability of the micelle govern many of the complex 
properties of milk and its industrial uses. The protein that 
allows the formation of micelles and determines micelle 
*To whom correspondence should be addressed. size and function is K-CN. It differs from other caseins in 
that it is soluble over a broad range of calcium ion 
concentrations and contains a hydrophilic c-terminal 
region. Kappa-CN is important in preventing micellar 
aggregation during the undesirable, thermally-induced 
gelation of milk and in the formation of cheese curd 
promoted by the enzymatic action of rennet. Milk with 
smaller casein micelles, and a greater surface concentra­
tion of K-CN, is more stable to heat than milk containing 
large micelles with less K-CN on the surface (Fox, 1982). 
Increased expression of K-CN protein in the mammary 
gland may reduce micelle size, increase the thermal 
stability of CN aggregates, and reduce the degree of 
coagulation and gelation in various milk products during 
the sterilization process of fluid milk (Jimenez-Flores and 
Richardson, 1988; Kang and Richardson, 1985; Wilmut et 
al., 1990; Clark, 1992; Yom and Bremel, 1993). 
Decreasing micelle diameter means there is a large 
micelle surface area to allow the formation of a firmer 
and more consistent curd. This dense coagulum retains a 
greater proportion of solids in the curd, resulting in a 
higher cheese yield (Schaar, 1981, 1984; Marziali and 
Ng-Kwai-Hang, 1986). 
After the initial work of Gordon et al. (1987) showing 
protein expression from a fusion gene directed to the 
mammary gland, numerous transgenic mouse models 
have been generated. Heterologous proteins expressed in 
mouse milk include sheep l3-lactoglobulin (Simons et al., 
1987; Whitelaw et al., 1992), guinea pig a-lactalbumin 
(Maschio et al., 1991), rat I3-CN (Lee et al., 1988, 1989), 
rat whey acidic protein (WAP) (Bayna and Rosen, 1990), 
bovine asl-casein (Yom et at., 1993), bovine-a-lacta1bu­
min (Vilotte et al., 1989; Bleck and Bremel, 1994), and 
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goat I3-CN (Persuy et al., 1992; Roberts et al., 1992). 
The high level of expression (24 mg ml- 1) that has been 
achieved with the goat I3-CN gene in the lactating 
mammary gland of transgenic mice (persuy et al., 1992) 
supports the goat I3-CN gene as a gene of choice for 
creating mammary expression cassettes for the production 
of transgenic animals. 
In this paper, the mammary tissue-specific expression 
of a bovine K-CN cDNA (b-K-CN) utilizing the goat 13­
CN gene as an expression cassette is reported. The tissue 
specificity and developmental-regulatory expression of 
the transgene are described at the mRNA and protein 
levels in three lines of transgenic mice with different 
numbers of copies of the transgene. 
Materials and methods 
Transgene construction 
The mammary gland-specific expression cassette used to 
direct expression of bovine K-CN to the milk of transgenic 
mice is shown in Fig. lAo The vector contained a partial 
K-CN cDNA sequence (815 nucleotides), from nucleotide 
35 of exon 1 to nucleotide 849 of the polyadenylation site 
in exon 5 (Stewart et al., 1984; EMBL accession number 
X00565), and a poly-A tail of 15 nucleotides (nt). The 
cDNA encompassed the K-CN translation initiation site 
(ATG), leader peptide, stop codon and untranslated 
regions of exons 4 and 5. The K-CN cDNA and poly-A 
tail were fused into exons 2 and 7 of the goat I3-CN gene 
(Roberts et al., 1992), with a 6.2-kb 5' and a 7.1-kb 3' of 
flanking regions of goat I3-CN. 
The K-CN cDNA clone was obtained from a Holstein 
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Fig. 1. (A) Structure and restriction map of the goat J3-CN bovine K-CN transgene. The 14 kb microinjection fragment contains the entire 
bovine K-CN cDNA fused between exons 2 and 7 of the goat J3-CN gene. Abbreviations: S, Sail; R, Eco RI. (B) Detail of the mutagenized 
region of the K-CN cDNA between amino acids 131 to 148. Top rows show the amino acid and nucleotide sequence of the K-CN A variant 
(original clone). Bottom rows show the nucleotides and amino acids changed to create the K-CN B construct. The nucleotides changed in 
the K-CN B construct correspond to silent mutations and codon alterations of amino acids 136 and 148. The Xba I site in the K-CN A 
sequence is underlined. 
cow mammary gland. The clone was identified from a 
AgtlO library and subcloned into pUC19. Sequence data 
showed two nucleotide differences between this clone and 
the published K-CN sequence (Stewart et al., 1984). One 
was a silent nucleotide change, C to T, in the codon of 
Ser-33, and the other was an A to G that changed the 
codon of Ser-155 to Gly. The K-CN cDNA was 
mutagenized to change the codon corresponding to Thr­
136 to Ile, and that of Asp-148 to Ala, thus matching the 
protein sequence of the K-CN B variant form. As shown 
in Fig. lB, several other nucleotides in the region 
between amino acids 131 to 148 were also changed. 
The 850 nt mutagenized cDNA K-CN was cloned from 
the pUC19 vector as an Xho I fragment and ligated into a 
goat f3-CN vector gbc 166 at the Xho I site, between exon 
2 and 7 of the goat f3-CN gene (Roberts et al., 1992). 
The whole construct used to produce transgenic mice 
was purified as a 14 kb Sall fragment (Fig. lA). The 
plasmid was prepared and cut with Sal I and run on a 1% 
TAE gel overnight to separate the fragments. The 14 kb 
fragment was electroeluted in dialysis tubing and then 
purified on a CsCl gradient. The band containing the 
DNA was removed, dialyzed and recovered by ethanol 
precipitation and resuspended in TE buffer. 
Generation and screening of transgenic mice 
Transgenic mice were generated by microinjection of 1­
2 ng fLl-1 of construct DNA into the pronuclear-stage 
mouse embryos obtained from CD1 female mice crossed 
with C57BL6J males. The microinjected embryos were 
transferred into pseudopregnant recipient mice. Of the 68 
progeny born, 16 transgenic mice were identified by 
Southern analysis of DNA extracted from tail biopsies. 
Blots were probed with a radiolabelled 670 bp Eco RI/ 
Hin dIll fragment of the bovine K-CN cDNA. The 
transgene copy number was determined using slot blots, 
by comparing the band intensity of the bovine K-CN gene 
(obtained from bovine DNA) with that of the mouse K-CN 
transgene on a densitometer (Ultroscan XL, LKB 
Bromma). 
DNA from progeny of founder mice was extracted 
from tail or toe clips of pups as described by Maga et al. 
(1994), and the presence of the transgene was assayed by 
PCR analysis. Primers JK6 (5' -CAA CTA CCA TGG 
CAC GTC AC-3') and JK7 (5'-CCG AAG GCA GAC 
AAC TGG-3'), specific for amplification of a 300 bp 
region of the b-K-CN cDNA, were used. Amplification 
was carried out in a total volume of 25 fLl of PCR mix 
containing 1 unit Taq polymerase (Promega), 2.5 fLl lOX 
buffer (Promega), 100 fLM each dNTp, 0.1 fLM each 
primer and 2.5 mM MgClz. PCR reaction were performed 
for 30 cycles at 92 DC (1 min), 60 DC (I min) and 72 DC 
(1 min). In the first PCR cycle denaturation was at 92 DC 
for 2 min. 
Homozygous animals were produced by mating hemi­
zygous transgenic animals. Pups were screened by semi­
quantitative PCR analysis and homozygosity confirmed 
by test mating. Semi-quantitative PCR was performed by 
comparing the amount of DNA amplified in two 
consecutive PCR cycles. Line BC-7 and BC-67 were 
run for 19 and 20 cycles and line BC-3l for 20 and 21 
cycles. PCR reactions were performed in a volume of 
50 fLl in a mixture containing 50 ng of tail DNA, 2 units 
Taq polymerase, 5 fLl lOX buffer, 100 fLM each dNTp, 
0.2 fLM each primer, 1.5 mM MgClz and 1 mgml- 1 
gelatin. Amplification conditions were 94 DC (1 min), 
64 DC (1.5 min) and 72 DC (2 min). In the first cycle 
denaturation was at 94 DC for 3 min. 
RNA isolation and northern analysis 
Total RNA was isolated by homogenization of tissues 
using an acid guanidinium thiocyanate-phenol-chloroform 
extraction method (Chomczynski and Sacchi, 1987). 
Northern analysis was performed as described by Maga 
et al. (1994) on total RNA extracted from mammary 
gland, kidney, liver, sublingual and submandibular salivary 
glands, spleen, lung, heart, skeletal muscle, skin, ovary 
and uterus of day-lO lactating transgenic females. 
Mammary gland of virgin females and females at day 2 
before parturition of days 4, 10 and 17 of lactation were 
also analysed (n = 3 females per treatment). Twenty fLg of 
total RNA were separated on MOPS/formaldehyde agarose 
gels and transferred to a nylon membrane (GeneScreen 
Plus, DuPont, Boston, MA) in the presence of lOX SSC. 
A 670 bp Eco RI/ Hin dIll fragment of the bovine K-CN 
cDNA, labelled with [a3Zp] dCTP (3000 Ci mmol- 1, 
Amersham, Arlington Heights, IL) by random priming, 
was used as probe to detect the b-K-CN mRNA. To detect 
the expression of endogenous WAP mRNA, a 560 bp Pst I 
fragment of the WAP cDNA was used. Hybridization was 
carried out overnight at 68 DC in the presence of 0.5 M 
sodium phosphate buffer and 7% SDS. Prior validation 
indicated that under these hybridization conditions that 
670 bp of the bovine K-CN cDNA did not hybridize to the 
endogenous mouse K-CN gene. Filters were washed in 2X 
SSC/O.l% SDS and O.2X SSC/O.1% SDS at room 
temperature for 30 min each. Autoradiography was 
performed at -70 DC overnight using Amersham X-ray 
film and scanned with a densitometer to obtain a mean 
absorbance value of signal present. Levels of message 
were quantified as a percentage of the amount of WAP 
message present on day 10 of lactation. 
Western analysis of transgenic mouse milk proteins 
Milk samples were collected on days 5, 10 and 15 of 
lactation from transgenic mice. The mother was separated 
from her pups for at least 3 h and injected intraperitone­
ally with 0.2 IV of oxytocin (Sigma, St. Louis, MO) to 
stimulate milk ejection. The milk was collected by a 
mechanical suction apparatus with the aid of vacuum into 
1.5 ml Eppendorf tubes. The milking was continued for 
each mouse until there was no further milk yield from any 
nipple. Approximately 1 to 1.5 ml of milk was collected 
per mouse. Milk was stored at -70°C until analysis. 
Milk proteins from mouse milk were separated using 
SDS-PAGE (Basch et al., 1985). Each milk sample was 
spun to remove fat, and from the skim milk a volumetric 
sample was taken and total protein determined by 
colorimetric assay (Bio-Rad protein assay). The samples 
were diluted 1:5 (vol/vol) with SDS loading buffer, and 
equal amounts of total protein were loaded into each well 
for SDS-PAGE. The proteins were then electrophoreti­
cally transferred to polyvinylidene difluoride membranes 
using a semi-dry transfer cell (Bio-Rad Laboratories). 
After transfer, the membranes were incubated overnight 
in TPBS (phosphate buffered saline with 0.1 % Tween­
20), followed by a 40-min incubation with 1:3000 (vol/ 
vol) dilution of primary antibodies (rabbit anti-bovine-K­
CN) in PBS-0.1 % Tween-20. Blots were washed with 
TPBS and affinity-purified goat anti-rabbit IgG conju­
gated to alkaline phosphatase (diluted I :4000 vol/vol, in 
TPBS) was applied to the blots. Blots were incubated for 
30 min with gentle agitation, with the second antibody 
and then washed. The K-CN band was detected using an 
alkaline phosphatase colour substrate solution (10 fJ-I 
hydrogen peroxide, 10 mg of 3,3'-diaminobenzedine 
(Sigma), and 10 ml PBS). 
Quantification from the western blots of bovine K-CN 
in mouse milk was done in triplicate using a digital 
densitometer with the Collage@ Software (Fotodyne, 
Hartland, WI). Each membrane contained seven mouse 
milk samples and three controls with different concentra­
tions of bovine K-CN (100, 150 and 200 fJ-gml-1). After 
developing the western blots, the images were digitized 
and a quantitative integration of the intensity and area for 
each band was performed. A linear standard curve was 
constructed from the controls and used to assign the 
fJ-g ml-1 of K-CN present in each of the mouse milk 
samples. 
Results 
Transgenic mice carrying a DNA construct containing a b­
K-CN cDNA with the 5' and 3' flanking DNA regions of 
the goat I3-CN regulatory expression elements were 
generated (Fig. 1). In 16 founder transgenic mice identi­
fied by Southern blotting, the transgene copy number 
varied between 1 and 20. One exceptional male had 
approximately 100 copies. For this work three lines were 
studied (BC-7, BC-31 and BC-67) with different copy 
numbers (Table 1), where the transgene was stably 
integrated and transmitted as a Mendelian locus. 
Northern analysis of ten different tissues collected from 
female transgenic mice on day 10 of lactation revealed 
that b-K-CN mRNA was expressed specifically in the 
mammary gland of lactating transgenic mice. Female 
mice of the lines BC-31 and BC-67, which had the 
higher level of expression of the transgene in the 
mammary gland, also showed a very low degree of 
expression of K-CN in salivary gland (Fig. 2). Transgene 
expression was not detected in other tissues tested. Line 
BC-7 with low b-K-CN expression in the mammary gland 
did not show transgene expression in any of the other 
tissues examined. Hybridization with a bovine K-CN­
specific probe yielded a single band larger than bovine K­
CN mRNA (1150 vs 900 nt respectively). The size was in 
agreement with the size of the bovine K-CN mRNA 
combined with part of the goat I3-CN exons present in 
the DNA construct (Fig. 3). 
The amount of b-K-CN mRNA detected in the 
mammary gland of day-10 lactating transgenic mice 
varied considerably from one line to the other (Table 1, 
Figs 2, 3 and 4). There was no association between 
transgene copy number and expression of the transgene. 
Line BC-7, which had an intermediate copy number (5­
10), had the lowest expression level; line BC-31 with one 
copy expressed approximately 50% of line BC-67 
carrying 20 copies of the transgene. Transgene expression 
in mammary gland was developmentally regulated in a 
Table 1. Characteristics of b-K-CN transgenic mouse lines 
Copy Expression of Bovine-K-CN 
number b-K-CN mRNAQ in milk 
Line (n = 5) (% ± SD) (n = 3) (mgmr1) ± SD 
Control 
BC-31 hemizygous ~I 69 ± 15.7 2.6 ± 1.0 
BC-31 homozygous 128 ± 19.8 3.8 ± 2.1 
BC-7 hemizygous 5-10 14 ± 7.6 0.9 ± 1.4 
BC-7 homozygous 25 ± 17.6 1.7 ± 0.8 
BC-67 hemizygous ~20 127 ±19.8 2.9 ± 0.9 
BC-67 homozygous 233 ± 28.1 3.7 ± 2.1 
aQuantity of b-K-CN mRNA compared with WAP mRNA in the mammary gland of 
day-lO lactating mice. 
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Fig. 2. Tissue specificity of b-K-CN transgene expression. Northern 
blot analysis of total RNA isolated from day-IO lactating females 
of lines BC-31, BC-7, BC-67, and control. Filters were probed 
with 32p with fragments of b-K-CN cDNA and murine WAP cDNA 
as described in Materials and methods. The tissues were 
nontransgenic mammary gland (Mg-), transgenic mammary gland 
(Mg+), salivary gland (Sg), liver (Li), kidney (Ki), ovary and 
uterus (0, U), heart (He), lung (Lu), skin (Si), spleen (Sp) and 
skeletal muscle (SM). The sizes of WAP and b-K-CN mRNAs were 
about 600 and 1150 nucleotides, respectively. 
similar manner to the expression of the endogenous 
mouse WAP gene (Fig. 4). When comparing transgene 
expression with the endogenous WAP gene expression, 
the highest expression of b-K-CN mRNA (line BC-67) 
was approximately 120% that of the endogenous WAP 
mRNA, while line BC-31 exhibited b-K-CN mRNA 
expression at approximately 77% of the endogenous 
WAP mRNA. Transgene expression in homozygous mice 
was approximately double that observed in hemizygous 
mice. 
The developmental regulation of b-K-CN expression 
was similar in the three transgenic lines (Figs 3 and 4). 
The principal difference was that lines BC-31 and BC-67 
expressed the transgene at low levels (2-3% of WAP) 2 
days prepartum, while BC-7 did not (FigA). The 
expression increased from day 4 to day 10 of lactation 
and then decreased by day 17 (Figs 3 and 4). Bovine K­
CN mRNA expression was not observed in mammary 
gland extracts from virgin transgenic mice (Fig. 3). 
The total protein was not significantly different at day 
5 and 15 of lactation, but at day 10 line BC-7 had 19% 
more protein that lines BC-31 and BC-67 (p < 0.05, one­
way ANOVA). Protein was measured to normalize the 
amount loaded in the gels for each sample (range: 40 to 
60 mgml- I ). Expression of b-K-CN was detected in all 
the transgenic lines, and no cross reaction was detected 
in the control mice. There seemed to be little association 
between the amount of mRNA in the cells (Fig. 4) and 
the total amount of b-K-CN expressed in the different 
lines of mice (Fig. 5). The three lines showed increased 
levels of b-K-CN at day 10 of lactation, when levels of 
mRNA were proportionally higher; however, the amount 
of protein expressed among the lines did not reflect the 
higher relative abundance of mRNA in lines BC-31 and 
BC-67. Furthermore, at day 15 of lactation there was a 
slightly higher level of K-CN in line BC-7 than in the 
other two lines. 
To study further the differences in expression levels of 
b-K-CN between hemizygous and homozygous mice, the 
western blots were repeated in a separate experiment 
using milk from the mice born two generations after 
those of the first experiment. Ten first parity female mice 
per line were sampled at day 10 of lactation (five 
hemizygous and five homozygous). The average expres-
C BC-31 BC-7 BC-67 B 
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Fig. 3. Representation of developmental regulation of b-K-CN expression in the mammary gland of lines BC-31, BC-7 and BC-67 
transgenic mice compared with endogenous mWAP gene expression. Northern blot analysis of one of the three animals analyzed per time 
point with 32p b-K-CN cDNA and WAP cDNA as probes. B, bovine mammary gland (5 fLg); C, nontransgenic day-1O lactating female; V, 
virgin transgenic mice; mammary gland from transgenic mice at 4, 10 and 17 days of lactation. The sizes of WAP, b-K-CN expressed by 
transgenic mice and endogenous b-K-CN (expressed by bovine mammary gland mRNAs were about 600, 900 and 1150 nucleotides, 
respectively. 
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Fig. 4. Developmental expression of b-K-CN mRNA during lacta­
tion. Relative level of b-k-CN mRNA compared with WAP mRNA 
(± SD) of line BC-7, BC-3l and BC-67 at day 10 of lactation. 
Three animals were analysed per line and time point. 
2.00...---------------------, 
1.75 II BC-7 
• BC-31 
~ 1.50 121 BC-67 
E 
l1.25 
5 1.00 
::, 
~ 0.75 
.~ 
aJ 0.50 
0.25 
o 
5 10 
Day of lactation 
Fig. 5. Developmental expression of b-K-CN during lactation. 
Quantification of the protein was realized by western blots 
analysing samples of three animals per line and time point. Mean 
b-K-CN concentrations (± SD) are shown at day 5, 10 and 15 of 
lactation for each transgenic line. 
sion of hemizygous mice was 0, 1.6 and 2.2 times higher 
than in the first experiment in lines BC-7, BC-3l and 
BC-67, respectively. Due to the high degree of variability 
in the expression of b-K-CN between animals of the same 
transgenic line (Fig. 6), the differences were not statisti­
cally significant, with the exception of line BC-67 
(p < 0.05, t-test). The mean values of b-K-CN expression 
were consistently higher in homozygous than hemizygous 
mice in all the lines (Fig. 6), although the differences 
were also not significant. 
The presence of b-K-CN expressed in mouse milk did 
not appear to affect the physiology of the mammary 
gland, and the growth of the pups was observed to be 
normal (data not shown). 
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Fig. 6. Expression of bovine K-CN on day 10 of lactation (separate 
experimental data from that shown in Fig. 5, see Results). Each 
point represents the level of bovine K-CN present in the milk 
samples from individual hemizygous (BC) and homozygous (HBC) 
mice from each transgenic line. The horizontal line represents the 
mean protein expression in each line. 
Discussion 
Transgenic mice were produced carrying the b-K-CN 
eDNA under the control of the goat 13-CN regulatory 
elements and this construct was tested for production of 
heterologous proteins in the milk of transgenic mice as a 
model for studying the production of increased amounts of 
b-K-CN in transgenic cows. To test the tissue specificity of 
expression of a transgene and to quantify possible 
alterations of the milk quality, it is practical first to 
introduce the construct into cheaper and easier-to-produce 
transgenic mice. 
Having in mind future experiments for the production 
of transgenic cattle, the construct developed was made to 
express a K-CN B variant protein, the least frequent 
variant in Holstein dairy cattle (Van Eenennaam and 
Medrano, 1991). Since the majority of Holstein embryos 
are of A type, the presence of this infrequent variant 
could often be used as a marker for detection of the 
casein protein produced by a transgene. The silent 
mutations in the construct (Fig. lB) were also introduced 
to be able to detect unequivocally the presence of 
transgene and to differentiate the transgene mRNA 
expression from the endogenous bovine K-CN mRNA in 
future experiments with cattle. 
The expression of eDNA-based foreign gene constructs 
in milk of transgenic animals has shown considerable 
variation when different promoters were used (reviewed 
by Yom et al., 1993). The presence of introns is essential 
in most cases for the transgene to be expressed 
(Whitelaw et al., 1991). With the goat 13-CN construct 
used in this study, the b-K-CN eDNA expression was 
relatively high and efficiently regulated in the three 
transgenic lines. The presence of three goat I3-CN introns 
seems to have fulfilled the role of modulating the 
regulated expression of the b-K-CN cDNA. Stringent 
tissue specificity and developmental programming of CN 
expression were observed. Similar results were reported 
for expression of the human cystic fibrosis transmem­
brane conductance regulator cDNA using a similar 
expression cassette, a 4.2-kb 5' and a 5.3-kb 3' flanking 
sequences to goat I3-CN exons (DiTullio et al., 1992). 
High-level expression of the goat I3-CN gene in mice 
under its own regulatory sequences, using 3-kb 5' and 6­
kb 3' flanking I3-CN regions (Persuy et al., 1992) or 4.2­
kb 5' and 5.3-kb 3' flanking sequences (Roberts et al., 
1992) has been reported. In contrast, expression was low 
in transgenic mice with a rat I3-CN genomic transgene 
composed of 3.5-kb 5' and 3-kb 3' flanking regions (Lee 
et al., 1988, 1989) and in transgenic rabbits with a 
chimaeric interleukin-2 gene driven by a 2-kb 5' flanking 
region of the rabbit I3-CN (Buhler et al., 1990). Some 
cis-acting elements essential for f3-CN gene expression 
could be absent in the shortened 5' and/or 3' flanking 
regions of rat and rabbit I3-CN construct used in the 
above reports; also possible is that negative cis-acting 
elements in the regions of rat and rabbit I3-CN are absent 
in the goat construct. 
Transgene expression was largely confined to the 
mammary gland of lactating transgenic mice. Only a 
small amount of b-K-CN mRNA was detected in the 
salivary gland. Using the goat I3-CN, Persuy et al. (1992) 
did not detect any transcripts in the salivary gland of one 
founder mouse tested. The ectopic expression observed in 
the salivary gland of two of the three lines tested here 
may be explained by the common structural character­
istics of the mammary and salivary glands (Whitelaw et 
al., 1992). Ectopic expression in the salivary gland has 
been reported in various transgenic lines using mouse 
WAp, ovine l3-lactoglobulin, or bovine as\-CN mammary 
gland-specific promoters (Pittius et al., 1988; Whitelaw 
et al., 1992; Maga et a/., 1994). 
The level of transgene mRNA expression was not 
associated with transgene copy number. This is a 
common phenomenon generally attributed to influences 
of the chromosomal sequences flanking the different sites 
of integration (Overbeek, 1994). Alternatively, when 
multiple copies are located in the genome, elements in 
copies located upstream may influence the activity of 
promoters located downstream (Bieberich et al., 1986; 
Palmiter and Brinster, 1986). However, homozygous 
females from the three lines expressed approximately 
twice the level of hemizygous animals at the mRNA 
level, which is the same result reported for two lines 
hemizygous and homozygous for a as\-CN-lysozyme 
transgene (Maga et al., 1994). These results could be 
expected for alleles with codominant expression and 
suggest that the availability of trans-acting factors in the 
mammary gland was not limiting. The results further 
support the concept that chromatin structure or cis-acting 
sequences affect the level of expression of transgenes 
within an insertional array, thus leading to copy number­
independent expression. 
The lack of association between the relative abundance 
of b-K-CN mRNA and the actual concentration of protein 
in the milk may have been caused by several species of 
mRNA being produced but only one being translated, or 
due to factors affecting the regulation of milk protein at 
the post-transcriptional, translational or post-translational 
levels in addition to transcription of the message 
(reviewed by Burgoyne and Wilde, 1994). Post-transcrip­
tional regulation of mRNA stability of milk proteins 
genes has been reported in mammary cell cultures, where 
the casein mRNA half-life was increased by prolactin, 
glucocorticoid and cell substratum (Eisenstein and Rosen, 
1988). Translational control of mammary protein synth­
esis has been reported in the rabbit (Devinoy et a/., 
1978), where high levels of induced casein mRNA were 
not accompanied by similar stimulation of casein 
synthesis. Devinoy et al. (1978) suggested that this 
phenomenon may reflect that the availability of transla­
tional machinery, such as aminoacyl-tRNA synthetases, is 
limiting milk protein synthesis. Post-translational regula­
tion of milk production also has been observed by 
intracellular turnover of newly-synthesized milk constitu­
ents (Wilde et al., 1991). Although transcriptional control 
is an important contributor to the regulation of endogen­
ous milk protein production, post-transcriptional events 
may have an important function in the regulation of 
expression of heterologous proteins in the milk of 
transgenic animals. 
The transgenic lines showed a high variation in b-K-CN 
protein levels among animals within the same line. 
Variation within transgenic lines in the expression of 
mammary-specific DNA constructs was reported for 
transgenic mice expressing bovine a-lactalbumin (Bleck 
and Bremel, 1994), and human lactoferrin with regulatory 
sequences from the bovine asl-CN gene (platenburg et 
al., 1994). Bleck and Bremel (1994) suggested that the 
variations were due to the genetic expression character­
istic of the a-lactalbumin transgene, and Platenburg et al. 
(1994) suggested that the differences could be due to the 
health of the mammary gland at the time of milking or 
by differing conditions during drawing of the milk that 
resulted in leakage of varying amounts of interstitial fluid 
into the milk. Characteristics of the goat I3-CN bovine K­
CN cDNA transgene construct could be the cause of 
differences at the gene expression level. Conversely, the 
differences observed may effectively reflect the 'normal' 
variation associated with the expression of transgenes in 
the mammary gland in animals of a heterogeneous 
genetic background. As expected in all milk-producing 
animals, variation in the relative levels of the endogenous 
caseins from individual' mice has been reported 
(Stevenson and Leaver, 1994), and this, together with 
the variability produced during milking, may also account 
for the high intra-line variation observed in this study. 
If the K-CN content of bovine milk were increased to 
similar concentrations as observed in these transgenic 
mice (0.9-3.8 mgml- 1), the percentage of K-CN relative 
to total caseins could be increased from an average 10% 
(3 mgml- 1; Yom and Bremel, 1993) to 13-22%. This 
increment may be sufficient to produce a significant 
reduction (22 to 40%) in the average size of the micelle 
(Donnelly et aI., 1984; Dalgleish et aI" 1989). Such a 
reduction, although still within the normal limits of the 
distribution of micelles sizes, could directly affect the 
physical properties of milk (e,g., curd gel strength), 
Substantial amounts of b-K-CN were produced from a 
single transgenic locus (line BC-31) by gene insertion, 
using the regulatory elements from the goat I3-CN gene. 
These results confirm that the protein composition of 
milk can be successfully manipulated without any 
observed adverse consequences and suggest this gene 
construct may be useful to target the expression of bovine 
K-CN to the lactating mammary gland of transgenic cattle 
in order to increase K-CN content relative to the other 
caseins. Preliminary comparative studies of milk from 
transgenic mice overexpressing b-K-CN and wild-type do 
not show any effect on the time of rennet coagulation, 
but there is an association with overexpression of b-K-CN 
and reduction of micelle size and production of a 
stronger curd in rennet-induced milk. These physical 
modifications in the milk properties are now being 
explored in detaiL 
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